Market Cap (In USD)
93.31 Thousand
Revenue (In USD)
4.39 Million
Net Income (In USD)
869.17 Thousand
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-4-0.0401
- PE
- -
- EPS
- -
- Beta Value
- 261.326
- ISIN
- US13767T1025
- CUSIP
- 13767T102
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Mark C. Mirken
- Employee Count
- -
- Website
- http://www.cannlabs.net
- Ipo Date
- 2014-06-13
- Details
- CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. is based in Denver, Colorado.
More Stocks
-
1066RHB Bank Berhad
1066
-
ALCUFAlpha Copper Corp.
ALCUF
-
2340
-
PRAPAT
-
LNKBLINKBANCORP, Inc.
LNKB
-
6387SAMCO Inc.
6387
-
DEMEDEME Group NV
DEME
-
MODVModivCare Inc.
MODV